Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinicopathological Significance of Lymphangiogenesis and Tumor Lymphovascular Invasion in Indonesian Breast Cancers

  • Widodo, Irianiwati (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) ;
  • Ferronika, Paranita (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) ;
  • Harijadi, Ahmad (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) ;
  • Triningsih, F.X. Ediati (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) ;
  • Utoro, Totok (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University) ;
  • Soeripto, Soeripto (Department of Anatomical Pathology, Faculty of Medicine, Gadjah Mada University)
  • Published : 2013.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Lymphangiogenesis, assessed as lymphovascular density (LVD), is the initial step of generalized tumor lymphovascular invasion (LVI). It also involves VEGF-C as the most important protein family. Lymphangiogenesis among breast cancer cases correlations with several clinicopathological factors are important to determine prognosis and treatment strategies, but results have been controversial and require clarification. Aim: To define correlations between VEGF-C expression, LVD and LVI with several clinicopathological parameters from Indonesian breast cancer patients. Materials and Methods: Using a cross-sectional study, a total of 48 paraffin-embedded tissues of breast cancer from Dr. Sardjito General Hospital Indonesia were assessed for VEGF-C expression, LVD and LVI by immunohistochemistry. Correlations of these markers with clinicopathological parameters like patient age, tumor size, lymph node status, grade, ER/PR and Her-2 status, cell proliferation and p-53 expression were investigated by linear analysis. Correlations of VEGF-C expression and LVI with several clinicopathological parameters were analyzed with Coefficient Contingency Chi-Square test. Results: The mean of patients age was 53.0 year, pre and post-menopausal patients accounting for 56.3% and 43.8%, respectively. Some 10.4% were well, 41.7% moderate and 47.9% poorly differentiated. ER positivity was evident in 50% while PR and Her-2 positivity was found in 31.3% and 33.3%, respectively. Breast cancer cells with over-expression of p-53 was 64.6% and with high cell proliferation was 56.3%. Lymph node metastasis was noted in 63.5%, and LVI in 72.9%. Significant correlations were found between LVD and tumor size (p:0.037), grade (p:0.000), lymphnode status (p:0.036), LVI (p:0.003), as well as with p-53 and cell proliferation. There were also significant correlation of VEGF-C (p:0.011) and LVI (p:0.001) with tumor grade. Only ER status was found to have a correlation with tumor size (p:0.027). Conclusions: This study suggested that in Indonesian breast cancer patients, lymphangiogenesis is correlated with tumor size, grade, lymph node status and tumor lymphovascular invasion, the latter also being related with p-53 over expression and high cell proliferation.

Keywords

References

  1. Beasley NJ, Prevo R, Banerji S, et al (2002). Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res, 62, 1315-20.
  2. Botting SK, Fouad H, Elwell K, Rampy BA, Salama SA, Freeman DH, Diaz-nastia CR. 2010. Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor3 in invasive squamous cell cervical cancer. Transl Oncol, 3, 170-5. https://doi.org/10.1593/tlo.09292
  3. Donegan WL (1997). Tumor related prognostic factor for breast cancer. Cancer J Clin, 47, 28. https://doi.org/10.3322/canjclin.47.1.28
  4. El Ghohary YM, Metwally G, Saad RS, et al (2008). Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol, 129, 578-86. https://doi.org/10.1309/2HGNJ1GU57JMBJAQ
  5. Furudoi A, Tanaka S, Haruma K, et al (2002). Clinical significance of VEGF-C and angiogenesis at the deepest invasive of advance colorectal carcinoma. Oncology, 62, 157-66. https://doi.org/10.1159/000048262
  6. Kinoshita J, Kitamura K, Kabashima A, et al (2001). Clinical significancer of vascular endothelial growth factors-C in breast cancer. Breast Cancer Res Treat, 66, 159-64. https://doi.org/10.1023/A:1010692132669
  7. Marinho VFZ, Metze K, Sanches FS, Rocha GFS, Gobbi H (2008). Lymph vascular invasion in invasive mammary carcinomas indentified by the endothelial lymphatic marker D2-40 is associated with other indicatiors of poor prognosis. BMC Cancer, 8, 64. https://doi.org/10.1186/1471-2407-8-64
  8. Nakamura Y, Yasuoka H, Tsujimoto M, et al (2003). Clinicopathological significance of VEGF-C in breast carcinoma with long-term follow-up. Mod Pathol, 16, 309-14. https://doi.org/10.1097/01.MP.0000062858.98295.9F
  9. Ogawa E, Takenaka K, Yanagihara K, et al (2004). Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br J Cancer, 91, 498-503. https://doi.org/10.1038/sj.bjc.6601992
  10. Papper MS (2001). Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res, 7, 462-8.
  11. Schoppmann SF, Bayer G, Aumayr K, et al (2004). Prognostic value of lymphangiogenesis and lymphovascular invasion in invasion in invasive breast cancer. Ann Surg, 240, 306-12. https://doi.org/10.1097/01.sla.0000133355.48672.22
  12. Schoppmann SF, Fenzl A, Nagy K, et al (2006). VEGF-C expressing TAMs in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery, 139, 839-46. https://doi.org/10.1016/j.surg.2005.12.008
  13. Sundar SS, Ganesa TS (2007). Role of lymphangiogenesis in Cancer. J Clin Oncol, 25, 4298-307. https://doi.org/10.1200/JCO.2006.07.1092
  14. Tavassoli FA, dan Devilee P (2003). WHO Classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs, IARC Press, Lyon.
  15. Teguh A, Harijadi, Ahmad G (2000) Correlation of clinical, pathological status, hormone receptor and C-erb-2 oncoprotein in breast cancer patients. Jpn J Cancer Chemother, 27, 600-6.
  16. Tezuka K, Onoda N, Takashima T, et al (2007). Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients. Oncol Rep, 17, 997-1003.
  17. Teramoto S, Arihiro K, Koseki M, et al (2008), Role of VEGF-C and D mRNA in breast cancer. Hiroshima J Med Sci, 57, 73-8
  18. Yavuz S, Paydas S, Disel U, Zorludemir S, Erdogan S (2005). VEGF-C expression in breast cancer: clinical importance. Adv Ther, 22, 368-77. https://doi.org/10.1007/BF02850084
  19. Yokoyama Y, Charnock-Jones DS, Licence D, et al (2003). VEGF-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer, 88, 237-44. https://doi.org/10.1038/sj.bjc.6600701
  20. Yonemura Y, Endo Y, Fijuta H, et al (1999). Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Mol Oncol, 5, 1823-9.
  21. Zhang XH, Huang DP, Guo GL, et al (2008) Coexpression of VEGF and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer, 8, 1-8. https://doi.org/10.1186/1471-2407-8-1

Cited by

  1. Clinicopathological Features of Indonesian Breast Cancers with Different Molecular Subtypes vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6109
  2. Effect of Lymphangiogenesis and Lymphovascular Invasion on the Survival Pattern of Breast Cancer Patients vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6287
  3. A Meta-Analysis of Lymphatic Vessel Invasion Correlated with Pathologic Factors in Invasive Breast Cancer vol.06, pp.04, 2015, https://doi.org/10.4236/jct.2015.64034
  4. Hormone Use is Associated with Lymphovascular Invasion in Breast Cancer vol.17, pp.3, 2016, https://doi.org/10.7314/APJCP.2016.17.3.1507
  5. Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers vol.96, pp.44, 2017, https://doi.org/10.1097/MD.0000000000008490